De Remer Capital Partners

Strategic partnerships, in-licensing, and acquisitions for our clients in the OTC and Pharmaceutical spaces. Prefer entities with products in or desire to be in the United States markets.

Activity:

- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- Cosmoceuticals
- Devices
- Drug delivery
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics

Therapeutic targets:

- Aging
- Cancer
- Hematology
- Infectious Diseases
- Oncology

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active: Australia/New-Zealand , North America , Europe , Far East

c. Countries active:

Corporate data:

Number of Employees: 8

Turnover:

Amount:	Year:	Currency:
00	2001	US Dollar

Year founded: 2000

Partners / Alliances: Strategic partner with FDA clinicians, leading scientists, and venture institutions. Example, fascilitated a global opthalmic transaction involving global conglomerate.